VICAL INC (74) | Business Finance (26)
Browse by Subcategory
Recent Contracts
-
Subscription and Investment Representation Agreement, dated May 25, 2022, by and between Brickell Biotech, Inc. and the purchaser signatory thereto
(Filed With SEC on May 25, 2022)
-
Asset Purchase Agreement, dated as of May 3, 2022, by and among Brickell Biotech, Inc., Brickell Subsidiary, Inc., Botanix SB Inc., and Botanix Pharmaceuticals Limited
(Filed With SEC on May 3, 2022)
-
Amended and Restated Underwriting Agreement, dated July 19, 2021, by and between Brickell Biotech, Inc. and H.C. Wainwright & Co., LLC
(Filed With SEC on July 22, 2021)
-
BRICKELL BIOTECH, INC. EMPLOYEE STOCK PURCHASE PLAN
(Filed With SEC on April 19, 2021)
-
Form of Warrant Agency Agreement
(Filed With SEC on October 13, 2020)
-
Registration Rights Agreement, dated February 17, 2020, by and between Brickell Biotech, Inc. and Lincoln Park Capital Fund, LLC
(Filed With SEC on February 18, 2020)
-
Funding Agreement, as amended, dated June 2, 2019, by and between Brickell Biotech, Inc. and NovaQuest Co-Investment Fund X, L.P
(Filed With SEC on September 3, 2019)
-
U.S. Security Agreement, dated August 31, 2019, by and between Brickell Biotech, Inc. and NovaQuest Co-Investment Fund X, L.P
(Filed With SEC on September 3, 2019)
-
Form of Underwriting Agreement
(Filed With SEC on October 22, 2020)
-
Form of Underwriting Agreement
(Filed With SEC on October 19, 2020)
-
Form of Pre-Funded Warrant
(Filed With SEC on October 13, 2020)
-
Form of Warrant to Purchase Common Stock
(Filed With SEC on October 13, 2020)
-
Form of Underwriting Agreement
(Filed With SEC on June 17, 2020)
-
Form of Warrant Agency Agreement
(Filed With SEC on June 17, 2020)
-
Form of Warrant to Purchase Common Stock
(Filed With SEC on June 17, 2020)
-
Form of Pre-Funded Warrant
(Filed With SEC on June 8, 2020)
-
Form of Warrant to Purchase Common Stock
(Filed With SEC on June 8, 2020)
-
Form of Underwriting Agreement
(Filed With SEC on June 8, 2020)
-
Purchase Agreement, dated February 17, 2020, by and between Brickell Biotech, Inc. and Lincoln Park Capital Fund, LLC
(Filed With SEC on February 18, 2020)
-
Series B Warrant issued by Brickell Biotech, Inc. to Lincoln Park Capital Fund, LLC
(Filed With SEC on February 18, 2020)
-
Series A Warrant issued by Brickell Biotech, Inc. to Lincoln Park Capital Fund, LLC
(Filed With SEC on February 18, 2020)
-
Securities Purchase Agreement, dated February 17, 2020, by and between Brickell Biotech, Inc. and Lincoln Park Capital Fund, LLC (schedules omitted)
(Filed With SEC on February 18, 2020)
-
Orca Pharmaceuticals LLC Asset Purchase Agreement, dated June 6, 2013, by and between Brickell Biotech, Inc. and Orca Pharmaceutics
(Filed With SEC on September 3, 2019)
-
Registration Rights Agreement, dated August 31, 2019, by and between Brickell Biotech, Inc. and NovaQuest Co-Investment Fund X, L.P
(Filed With SEC on September 3, 2019)
-
Panmira Pharmaceuticals LLC Purchase Agreement, dated January 30, 2015, by and between Brickell Biotech, Inc. and Panmira Pharmaceuticals
(Filed With SEC on September 3, 2019)
-
Form of Warrant Certificate
(Filed With SEC on September 3, 2019)